AIFF: Firefly Neuroscience Total Debt to Capital

The price visualization on GURU.Markets for Firefly Neuroscience, Inc (AIFF), which assists in the basic asset valuation, shows a debt-to-equity ratio of 0.00. Firefly Neuroscience, Inc is developing an AI environment for brain function analysis, expanding its network of clinics in the US thanks to FDA certification. The business monetizes cloud services for psychiatrists, creating high software dependency among specialists, while minimizing risks through the accurate detection of dementia.

Firefly Neuroscience, Inc (AIFF) is developing patent-protected AI algorithms for EEG analysis, which requires significant investment in FDA certification. The trend in total debt-to-equity ratio demonstrates the company's level of reliance on borrowed funds, measuring financial stability risk through the proportion of liabilities to equity, which allows investors to assess the business's margin of safety while scaling medical technologies.